Approved for FLUARIX is indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccine [see Description ( 11 )] . FLUARIX is approved for use in persons aged 6 months and older.. Specific levels of hemagglutination-inhibition (HI) antibody titer post-vaccination with inactivated influenza virus vaccines have not…
Loading full data from Know Your Drugs Institute…